|
Post by spiro on Oct 20, 2016 22:31:29 GMT -5
mnkdfann,
It might be blasphemy to compare the 27 gram per serving Viva Puffs to the 18 gram per serving Mallomars. Also a purchase of Mallomars now can be directly linked to a 30% increase in the MNKD share price.
Spiro here, BTW, those Viva Puff Rasperry things looked pretty darn good.
|
|
|
Post by spiro on Oct 20, 2016 21:37:40 GMT -5
Spiro knows exactly why MNKD's share price went up today. It happened after Spiro bought his first box of Mallomars last night. What else could it possibly be?
Spiro here, enjoying a Mallomar
|
|
|
Post by spiro on Sept 27, 2016 20:44:48 GMT -5
mannmade,
I have never heard Trump talk about this issue.
|
|
|
Post by spiro on Aug 25, 2016 15:36:46 GMT -5
Baba, believe it or not, Mankind Cares actually does care. My pharmacist actually asked me, who the heck are these Mankind Cares guys? It remains to be seen, if Endo's will be smart enough to utilize the services of Mankind Cares to help not only themselves, but also their patients in the pre- authorization process with the insurance companies. Hopefully in several month's NRx numbers could start to see the impact of this help.
Spiro here, 2 boxes in the fridge and 2 more coming next month.
|
|
|
Post by spiro on Aug 25, 2016 12:18:55 GMT -5
Ok, it's time for Spiro to share his story. On Aug 12, 2016 Spiro's insurance company said in a letter, " We have reviewed your request to obtain Afrezza under your medicare prescription drug plan. This request has been approved until 12/31.16. After that date my doctor will have to resubmit a letter of medical neccesity as she did for the first prescription. The next day, Spiro goes to the pharmacy to pick up his Afrezza and was told that his insurance company would not cover Afrezza. The pharmacist calls the insurance hot line and was told that they could not cover Afrezza because there was no such drug, even though the pharmacist had 2 boxes in his hand. The pharmacist was told, that the NDC number was only for non medicare patients. Spiro being out of Afrezza dug very deep into his cheap Greek wallet and forked over $315. Good health is more important than money. Upon arriving home, the empty wallet Spiro called Roberta at MNKD, who then contacted a guy named Quintero. Spiro was called back within minutes by Quintero, who got Spiro connected to Mankind Cares. Several hours later Spiro was contacted by Mannkind Cares. Spiro was immediately e-mailed a patient authorization form, which he filled out and faxed back to MNKD Cares. During the next 3 days, Spiro spoke to at least 4 different people at Mannkind cares. Apparently Mankind Cares really does care. They contacted Spiro's doctor several times, requested and received the necessary documentation. They contacted Spiro's insurance company and pharmacist several times. Spiro was called numerous times by Mankind cares to keep him informed. Tuesday, Spiro was called and informed by Mannkind Cares that his prescription was ready to pick up at his pharmacy and that his co-pay would be $70 for his 2 boxes of 4 unit cartridges. He was was also told that the pharmacist would replenish his depleted wallet with a $315 refund. Spiro has been rather shocked by the incredible aggressiveness and efficiency of Mankind Cares. Spiro does not know what Mankind Cares did to convince his insurance company to cover Afrezza, but they damn sure got the job done.
Spiro here, It sure seems that MNKD is getting it's act together
|
|
|
Post by spiro on Aug 17, 2016 8:07:39 GMT -5
Spiro has noticed that his olfactory nerve appears to working exceptional, but he is not sure if his nasal mucosa along with his neurons are in peak condition. But Spiro is definitely sure that Afrezza continues to help control his diabetes for over 18 month's now, despite some recent weight gain and reduced exercise.
Spiro here, crunch time is coming
|
|
|
Post by spiro on Aug 9, 2016 17:26:44 GMT -5
Compound,
Nice synopsis on where MNKD stands, no argument from Spiro. MNKD is finally starting to sound like they are focused and know exactly what they are doing.
Spiro here, admitting that he had to hit his margin account to buy more patience this year. But all is well.
|
|
|
Post by spiro on Jul 15, 2016 13:41:59 GMT -5
Thank you for the referral Baba, but Spiro thinks we all need help, if we are still holding MNKD. Spiro knew his post would be misunderstood by some , but he didn't expect the Baba to be so clueless.
Spiro here, just trying to make " MNKD Great Again. " Afrezza already is great, but it's too bad that most diabetics don't know about it yet.
|
|
|
Post by spiro on Jul 15, 2016 11:52:48 GMT -5
Spiro's focus is mostly on refills and retention of adapters. If Sanofi had retained 75% of tit's users, they would still be selling the drug now. The only way Afrezza doesn't work great in most people is improper dosage. The new packaging should keep the costs down for the user and provide the ability to increase dosage with larger meals. Clearly Spiro hopes that NRx will be higher than 212. Spiro wants the TRX to be over 500, which would indicate retention of users. Sanofi only had a TRx of 257 which indicated a poor refill rate. If by week 12, the NRx were 1000 and the TRx were 1100, that would be very troubling for Spiro.
Spiro here, it's all about refills and satisfied new users.
|
|
|
Post by spiro on Jul 15, 2016 9:27:54 GMT -5
Spiro believes that in order for MNKD's share price to make significant advancement, barring some unexpected positive development not related to Afrezza, it will be necessary for MNKD to meet certain Afrezza sales levels. After studying Sanofi's early launch numbers, Spiro has decided that he would like to see some progress in sales by week 12 of MNKD's launch. At week 12, SNY only had 210 NRX and 257 TRx. It appears that Sanofi was only achieving about a 20% refill rate. Spiro's definition of progress is focused not only only on NRx numbers but mostly on the need to reach 50- 75% or higher refill rates. Spiro believes that Afrezza's new packaging will be likely the key to MNKD reaching and easily beating Sanofi's refill rates. Spiro is very confident that Mike and Matt have the pieces in place and the proper strategy to make Afrezza a successful alternative to injecting.
Spiro here, just talking to himself out loud and hoping that he is somewhat correct?
|
|
|
Post by spiro on Jul 13, 2016 10:47:04 GMT -5
Signed
|
|
|
Post by spiro on Jun 24, 2016 11:04:24 GMT -5
Blind hog thanks for sharing. What Sanofi did to Afrezza was criminal.
Spiro here, time is our enemy, but Afrezza is our friend.
|
|
|
Post by spiro on Jun 15, 2016 19:52:10 GMT -5
Spiro used to love the company, now he only likes MNKD. It was a blind love, Spiro would spend every loose dollar he had on MNKD shares and options. Those days are over. Spiro at 70 has finally gotten older and slightly wiser. He still refuses to sell any shares, but I least he is not buying new positions. Spiro thinks that MNKD has about until Novemebr, to show some serious progress in script numbers. The big question remains. What is serious progress? Maybe, at least doubling Sanofi's sales?
Spiro here, Siberia seems to be getting closer
|
|
|
Post by spiro on Apr 28, 2016 21:03:23 GMT -5
Did it ever occur to you guys that Spiro might be taking African Medicine Man classes. That little peace pipe is damn good device to smoke after eating. Mnholdem knows his stuff, Spiro has been a winner since that first day, when he started using Afrezza.
Spiro here, a temporary financial loser, but a big time winner with his diabetes treatment.
|
|
|
Post by spiro on Apr 25, 2016 8:24:28 GMT -5
This one will last longer than one day for Spiro. Sanofi executives next?
Spiro here, good news is good news.
|
|